The decision on starting a diagnostic trajectory for dementia is considered a preference-based decision since the considerations and values of patients regarding the timing of initiating testing may v
The aim of this study was to develop and evaluate a proof-of-concept open-source individualized Patient Decision Aid (iPDA) with a group of patients, physicians, and computer scientists. The iPDA was
* 51 eligible women * Offered a custom-designed DA focussed on the decision about neoadjuvant systemic therapy. * An assessment will be made of its utility and acceptability for patients and investiga